In a recent interview for IEG Policy's new special report titled Smart
Solutions for Food and Farming: A Policy Perspective, EuropaBio's Secretary
General, Joanna Dupont-Inglis talked about her organization's views on the
European Union's policy on GM crops and genome editing.

Dupont-Englis said she objects the European Court of Justice ruling in July
2018 because the ruling could cause European life science innovation to
grind to a halt, citing that Europe's world-leading scientific community is
also calling for change. She added that the EU's approval system has already
prevented farmers from accessing products that have been used safely for
decades in other parts of the globe. According to her, the existing system
for GMOs in the EU could and should work much more smoothly, even within the
existing Directive.

Dupont-Inglis said, "Any products classified as GMOs have little chance of
ever gaining fair market access in the EU. EuropaBio firmly believes that,
in order to advance the UN Sustainable Development Goals by 2030, a
proportionate, fit-for-purpose, and science-based approach to modern
technologies, such as innovative biotechnology and life sciences, is
essential."

As EuropaBio's Secretary General, she sees the promising potential
applications of genome editing in the development of pest and disease
resistant fruit and vegetables, products with lower allergenic potential,
healthier soybean oils that reduce trans-fats, cereals that use water more
efficiently, as well as crops with improved yields, and those that can
reduce waste.

[iegvu.agribusinessintelligence.informa.com]
Bio-head-calls-for-change-in-EUs-ag-tech-approval-system